Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1996 Feb;40(2):358–361. doi: 10.1128/aac.40.2.358

In vitro and in vivo inhibition of erythrocytic development of malarial parasites by docetaxel.

V Sinou 1, P Grellier 1, J Schrevel 1
PMCID: PMC163116  PMID: 8834880

Abstract

The stage-dependent susceptibility of Plasmodium falciparum to a short exposure to docetaxel (Taxotere) was evaluated by subjecting ring-infected, trophozoite-infected, and schizont-infected erythrocytes to a 5-h exposure to various concentrations of the drug. The schizont stage was shown to be the most sensitive stage; an inhibition of more than 60% of parasite development was observed at 10 nM. At this drug concentration, the development of the younger ring and trophozoite forms was unaffected. The in vivo antimalarial activity of docetaxel against the development in blood of old trophozoites of a species that causes malaria in rodents, Plasmodium vinckei petteri, was evaluated in IOPS-OF1 mice. Two tests were performed: the 4-day suppressive test, as described by Peters (W. Peters, p. 145-273, in Chemotherapy, and Drug Resistance in Malaria, vol. 1, 1987), and the effects of a single injection of docetaxel after inoculation of the parasites. A single injection of docetaxel at 40 mg/kg of body weight was sufficient to reduce drastically the level of parasitemia; 90% inhibition of the development of parasites in blood was observed 5 days after drug injection. This program avoided the toxicity observed when mice were treated with four injections of docetaxel. The possibility of using a single bolus of taxoids to treat malaria infections is discussed.

Full Text

The Full Text of this article is available as a PDF (203.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aikawa M., Beaudoin R. L. Studies on nuclear division of a malarial parasite under pyrimethamine treatment. J Cell Biol. 1968 Dec;39(3):749–754. doi: 10.1083/jcb.39.3.749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aikawa M., Carter R., Ito Y., Nijhout M. M. New observations on gametogenesis, fertilization, and zygote transformation in Plasmodium gallinaceum. J Protozool. 1984 Aug;31(3):403–413. doi: 10.1111/j.1550-7408.1984.tb02987.x. [DOI] [PubMed] [Google Scholar]
  3. Caillard V., Beauté-Lafitte A., Chabaud A. G., Landau I. Plasmodium vinckei petteri: identification of the stages sensitive to arteether. Exp Parasitol. 1992 Dec;75(4):449–456. doi: 10.1016/0014-4894(92)90258-c. [DOI] [PubMed] [Google Scholar]
  4. Dieckmann-Schuppert A., Franklin R. M. Compounds binding to cytoskeletal proteins are active against Plasmodium falciparum in vitro. Cell Biol Int Rep. 1989 May;13(5):411–418. doi: 10.1016/0309-1651(89)90135-5. [DOI] [PubMed] [Google Scholar]
  5. Guéritte-Voegelein F., Guénard D., Lavelle F., Le Goff M. T., Mangatal L., Potier P. Relationships between the structure of taxol analogues and their antimitotic activity. J Med Chem. 1991 Mar;34(3):992–998. doi: 10.1021/jm00107a017. [DOI] [PubMed] [Google Scholar]
  6. Kumar N., Aikawa M., Grotendorst C. Plasmodium gallinaceum: critical role for microtubules in the transformation of zygotes into Ookinetes. Exp Parasitol. 1985 Apr;59(2):239–247. doi: 10.1016/0014-4894(85)90078-5. [DOI] [PubMed] [Google Scholar]
  7. Kwiatkowski D., Hill A. V., Sambou I., Twumasi P., Castracane J., Manogue K. R., Cerami A., Brewster D. R., Greenwood B. M. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet. 1990 Nov 17;336(8725):1201–1204. doi: 10.1016/0140-6736(90)92827-5. [DOI] [PubMed] [Google Scholar]
  8. Lambros C., Vanderberg J. P. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol. 1979 Jun;65(3):418–420. [PubMed] [Google Scholar]
  9. Meis J. F., Verhave J. P., Jap P. H., Meuwissen J. H. Transformation of sporozoites of Plasmodium berghei into exoerythrocytic forms in the liver of its mammalian host. Cell Tissue Res. 1985;241(2):353–360. doi: 10.1007/BF00217180. [DOI] [PubMed] [Google Scholar]
  10. Montalvo-Alvarez A. M., Landau I., Baccam D., Chabaud A. G., Ginsburg H. Experimental modifications of the circadian rythm of Plasmodium vinckei petteri following cryopreservation; probable resistance of the merozoïte to thawing. C R Acad Sci III. 1988;307(1):5–10. [PubMed] [Google Scholar]
  11. Pasvol G., Wilson R. J., Smalley M. E., Brown J. Separation of viable schizont-infected red cells of Plasmodium falciparum from human blood. Ann Trop Med Parasitol. 1978 Feb;72(1):87–88. doi: 10.1080/00034983.1978.11719283. [DOI] [PubMed] [Google Scholar]
  12. Pouvelle B., Farley P. J., Long C. A., Taraschi T. F. Taxol arrests the development of blood-stage Plasmodium falciparum in vitro and Plasmodium chabaudi adami in malaria-infected mice. J Clin Invest. 1994 Jul;94(1):413–417. doi: 10.1172/JCI117338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Read M., Sherwin T., Holloway S. P., Gull K., Hyde J. E. Microtubular organization visualized by immunofluorescence microscopy during erythrocytic schizogony in Plasmodium falciparum and investigation of post-translational modifications of parasite tubulin. Parasitology. 1993 Apr;106(Pt 3):223–232. doi: 10.1017/s0031182000075041. [DOI] [PubMed] [Google Scholar]
  14. Ringel I., Horwitz S. B. Studies with RP 56976 (taxotere): a semisynthetic analogue of taxol. J Natl Cancer Inst. 1991 Feb 20;83(4):288–291. doi: 10.1093/jnci/83.4.288. [DOI] [PubMed] [Google Scholar]
  15. Rowinsky E. K., Cazenave L. A., Donehower R. C. Taxol: a novel investigational antimicrotubule agent. J Natl Cancer Inst. 1990 Aug 1;82(15):1247–1259. doi: 10.1093/jnci/82.15.1247. [DOI] [PubMed] [Google Scholar]
  16. Schiff P. B., Horwitz S. B. Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci U S A. 1980 Mar;77(3):1561–1565. doi: 10.1073/pnas.77.3.1561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Schrével J., Asfaux-Foucher G., Bafort J. M. Etude ultrastructurale des mitoses multiples au cours de la sporogonie du Plasmodium b. berghei. J Ultrastruct Res. 1977 Jun;59(3):332–350. doi: 10.1016/s0022-5320(77)90043-0. [DOI] [PubMed] [Google Scholar]
  18. Schrével J., Sinou V., Grellier P., Frappier F., Guénard D., Potier P. Interactions between docetaxel (Taxotere) and Plasmodium falciparum-infected erythrocytes. Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8472–8476. doi: 10.1073/pnas.91.18.8472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Sinden R. E., Canning E. U., Spain B. Gametogenesis and fertilization in Plasmodium yoelii nigeriensis: a transmission electron microscope study. Proc R Soc Lond B Biol Sci. 1976 Mar 30;193(1110):55–76. doi: 10.1098/rspb.1976.0031. [DOI] [PubMed] [Google Scholar]
  20. Strüchler D. How much malaria is there worldwide? Parasitol Today. 1989 Feb;5(2):39–40. doi: 10.1016/0169-4758(89)90188-9. [DOI] [PubMed] [Google Scholar]
  21. Trager W., Jensen J. B. Human malaria parasites in continuous culture. Science. 1976 Aug 20;193(4254):673–675. doi: 10.1126/science.781840. [DOI] [PubMed] [Google Scholar]
  22. Usanga E. A., O'Brien E., Luzzato L. Mitotic inhibitors arrest the growth of Plasmodium falciparum. FEBS Lett. 1986 Dec 1;209(1):23–27. doi: 10.1016/0014-5793(86)81077-8. [DOI] [PubMed] [Google Scholar]
  23. Wani M. C., Taylor H. L., Wall M. E., Coggon P., McPhail A. T. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc. 1971 May 5;93(9):2325–2327. doi: 10.1021/ja00738a045. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES